Cover Image
市場調查報告書

慢性腦脊髓靜脈功能不全 (CCSVI) :全球臨床實驗趨勢

Chronic Cerebrospinal Venous Insufficiency (CCSVI) Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 349802
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
慢性腦脊髓靜脈功能不全 (CCSVI) :全球臨床實驗趨勢 Chronic Cerebrospinal Venous Insufficiency (CCSVI) Global Clinical Trials Review, H2, 2015
出版日期: 2015年12月16日 內容資訊: 英文 26 Pages
簡介

本報告提供慢性腦脊髓靜脈功能不全 (CCSVI) 治療藥相關之臨床實驗趨勢調查,提供您臨床實驗數量及受驗人數,各階段狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 歐洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上慢性腦脊髓靜脈功能不全 (CCSVI) 的比例

E7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上慢性腦脊髓靜脈功能不全 (CCSVI) 的比例

各階段臨床實驗數量

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

有潛力的贊助商

慢性腦脊髓靜脈功能不全 (CCSVI) 治療藥臨床實驗主要的參與企業

臨床實驗簡介概要

附錄

目錄
Product Code: GDHC3109CTIDB

GlobalData's clinical trial report, "Chronic Cerebrospinal Venous Insufficiency (CCSVI) Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Cerebrospinal Venous Insufficiency (CCSVI) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Cerebrospinal Venous Insufficiency (CCSVI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Chronic Cerebrospinal Venous Insufficiency (CCSVI) to Central Nervous System Clinical Trials
  • Clinical Trials by E7 Countries: Proportion of Chronic Cerebrospinal Venous Insufficiency (CCSVI) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Prominent Sponsors
    • Top Companies Participating in Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics Clinical Trials
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics, Global, Clinical Trials by Region, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Chronic Cerebrospinal Venous Insufficiency (CCSVI) to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Proportion of Chronic Cerebrospinal Venous Insufficiency (CCSVI) to Central Nervous System Clinical Trials, E7 Countries (%), 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*

List of Figures

  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Proportion of Chronic Cerebrospinal Venous Insufficiency (CCSVI) to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Proportion of Chronic Cerebrospinal Venous Insufficiency (CCSVI) to Central Nervous System Clinical Trials, E7 Countries (%), 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Chronic Cerebrospinal Venous Insufficiency (CCSVI) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • GlobalData Methodology
Back to Top